As a not-for-profit clinic, we at Merrion Fertility Clinic and the National Maternity Hospital are passionate about fairness and making our treatment as affordable as possible for all our patients. We urge patients and the general public to carefully consider all the information regarding different treatments and pricing.
And we encourage you to write to the Minister for Health advocating for public funding of IVF for all Irish patients.
Despite the official government announcement last year that €1 million would be allocated for public IVF funding, these funds have still not been released. Those awaiting the much-needed financial and legal supports around assisted reproduction, as promised by the then Health Minister Leo Varadkar three years ago, continue to face uncertainty about when these funds will be made available and what criteria will be required to qualify for assistance.
The Government approved the IVF financial aid plans in October 2017 and a specific €1m fund was then announced by the Taoiseach last December.
In a statement, the Department of Health said a model of care for infertility, tied to long-awaited assisted human reproduction (AHR) legislation and the provision of financial assistance, was still being worked on by officials.
MFC continue to advocate for public funding of IVF for all Irish patients.
To read the Irish Examiner article, please see below:
Dr. Helen Spillane of MFC recently took part in a conference at The Centre for Reproductive Medicine of Universitair Ziekenhuis Brussels. The clinic is a world leader in research, education, development and treatment in Assisted Reproduction & Preimplantation Genetic Diagnosis, performing 5,500 cycles of IVF/ICSI yearly.
The Human Fertility and Embryology Authority has just released its latest report on trends and figures in fertility treatment. Their findings have been welcomed by the British Fertility Society, who highlight the increased uptake of fertility treatment, improved success rates and confirmation that “IVF remains a safe and effective approach to address fertility issues”. Figures in the report also show that multiple births, the single biggest health risk from IVF, has now reached an all-time low of 10%, a sharp decline from 24% in 2008.
Other key highlights from the report include:
- in 2017, more than 54,000 patients underwent around 75,000 fertility treatments in the U.K, with IVF treatment cycles increasing by 2.5% since 2016 and resulting in over 20,500 babies being born.
- the average birth rate for women of all ages using their own eggs reaching 22%, while women under 35 using their own eggs have the highest birth rates (30% – fresh embryo cycle, 27% – frozen embryo cycle.
- the fastest growing fertility treatment type is egg freezing, which has increased by 10% since 2016 to 1,463 cycles in 2017.
- frozen embryo treatment cycle success rates (23%) have overtaken fresh embryo cycle success rates (22%) for the first time since records began, indicating that freezing embryos can give as much chance of success as a fresh cycle.
To read the HFEA press release and access the report, please follow the link below:
For the British Fertility Society response to the HFEA report on trends and figures in fertility treatment, please follow the link below:
In at least 50% of cases of male factor infertility, the cause is unknown. A number of lifestyle factors have been shown to affect male fertility. These include diet and nutrition, body weight, levels of exercise, stress and use of tobacco and drugs. Tackling obesity, improving your diet and incorporating moderate-intensity aerobic exercise into your daily life can boost fertility, improve chances of conception, and allow you to be proactive about your role in conceiving a baby. To read more please follow the link below:
Merrion Fertility Clinic were delighted to participate in the 18th World Congress of the Academy of Human Reproduction, held in the Convention Centre Dublin on April 3-6th.
MFC research was high on the agenda, with invited talks by both Prof. Wingfield and Dr. Allen, as well as six research presentations by clinical fellows Dr. Hartigan, Dr. Crosby and research officer Dr. Glover.
Congratulations to all!
As a not-for-profit clinic, we at Merrion Fertility Clinic and the National Maternity Hospital are passionate about fairness and making our treatment as affordable as possible for all our patients. An Irish IVF Clinic group has recently advertised an IVF refund scheme and other payment incentives for treatment. In the past, we have carefully explored such schemes whereby patients only pay for their IVF treatment if they are successful and have a baby. While some people will be lucky with such an arrangement, others will end up paying more than they need to. It is our considered opinion that such schemes do not reduce costs overall for the majority of patients and that they may even be unethical. We are not aware of any other branch of medicine where patients are asked to pay up front for several episodes of treatment – in case the first treatment does not work.
In 2017 in Merrion Fertility Clinic, for couples undergoing IVF where the woman was under 35 years, 45% had a livebirth on their first cycle of treatment and 79% of those also had embryos to freeze for the future. They paid for one cycle of treatment. If they had opted for a ‘no baby no fee’ scheme, each couple would effectively have paid an unnecessary €6,000-€7,000 for two fresh cycles they never needed and the clinic would have made a nice profit. Incentive schemes are subject to medical review such that only patients with a good prognosis for success are deemed eligible and there is little transparency about the kind of clinical criteria that need to be met. The schemes also discriminate against couples who do not have €10,000 to €17,000 to spend. There are many other cost considerations also – for instance, Merrion Fertility Clinic does not charge for embryoscope or for sedation administered by Consultant Anesthetists. These services which are included in our base fee are not included in incentive schemes.
In multi-cycle fixed schemes, patients who do very poorly on their first cycle (e.g. get no eggs) will be locked into paying for two cycles, with no refund if they do not conceive. With a pay-as-you-go policy such as ours, such patients may decide to stop after one treatment and will only pay for that one treatment.
It is important to note that the companies offering these incentive schemes are commercial companies with shareholders who want to see a return on their investment. Their investment in fertility clinics reflects the sad but increasing commercialization of fertility treatment, with fertility care (in particular IVF) now being recognized internationally as ‘big business’ offering attractive financial returns. We are not alone in raising questions about incentive schemes for treatment. This recent article from Prof Nicky Hudson (Centre for Reproduction Research) discusses the growing commercialisation of fertility treatment in the UK and internationally, and what this means for the potential exploitation of patients.
We urge patients and the general public to carefully consider how they choose to pay for fertility treatment. And we encourage you to write to the Minister for Health advocating for public funding of IVF for all Irish patients.
Fertility specialists are advocating for a change in existing U.K. laws that require women who freeze their eggs to use them within 10 years. This time limit does not take into account the remarkable technological advances that have been made in the field, including the introduction of a greatly improved egg-freezing technique called vitrification. As a growing number of women pursue egg freezing in order to preserve their fertility, advocates argue that there is a growing need to update the current legislation around fertility.
To read more, please follow the link below: